This CincyTech Portfolio Company is Developing a Drug for Viral Infection Treatment
Generally if a patient is infected with a viral disease, there are only two main treatment options: vaccines and direct antiviral medication. However, the Columbus-based startup Invirsa is developing a new treatment approach.
Currently in the preclinical stage, the drug being developed by Invirsa supports the body’s natural immune response to viral infections, while also stimulating the repair of damaged cells.
Click here to read the complete article. Story excerpt provided by American Inno. Written by Cassie Lipp. Originally published June 28, 2018.
Leave a Reply